Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults
- PMID: 31820365
- PMCID: PMC7067721
- DOI: 10.1007/s40268-019-00291-2
Extrapolation of Drug Clearance in Children ≤ 2 Years of Age from Empirical Models Using Data from Children (> 2 Years) and Adults
Abstract
Background: The application of modeling and simulation approaches in clinical pharmacology studies has gained momentum over the last 20 years.
Objectives: The objective of this study was to develop six empirical models from clearance data obtained from children aged > 2 years and adults to evaluate the suitability of the models to predict drug clearance in children aged ≤ 2 years (preterm, term, and infants).
Methods: Ten drugs were included in this study and administered intravenously: alfentanil, amikacin, busulfan, cefetamet, meperidine, oxycodone, propofol, sufentanil, theophylline, and tobramycin. These drugs were selected according to the availability of individual subjects' weight, age, and clearance data (concentration-time data for these drugs were not available to the author). The chosen drugs are eliminated by extensive metabolism by either the renal route or both the renal and hepatic routes. The six empirical models were (1) age and body weight-dependent sigmoidal maximum possible effect (Emax) maturation model, (2) body weight-dependent sigmoidal Emax model, (3) uridine 5'-diphospho [body weight-dependent allometric exponent model (BDE)], (4) age-dependent allometric exponent model (ADE), (5) a semi-physiological model, and (6) an allometric model developed from children aged > 2 years to adults. The model-predicted clearance values were compared with observed clearance values in an individual child. In this analysis, a prediction error of ≤ 50% for mean or individual clearance values was considered acceptable.
Results: Across all age groups and the ten drugs, data for 282 children were compared between observed and model-predicted clearance values. The validation data consisted of 33 observations (sum of different age groups for ten drugs). Only three of the six models (body weight-dependent sigmoidal Emax model, ADE, and semi-physiological model) provided reasonably accurate predictions of clearance (> 80% observation with ≤ 50% prediction error) in children aged ≤ 2 years. In most instances, individual predicted clearance values were erratic (as indicated by % error) and were not in agreement with the observed clearance values.
Conclusions: The study indicated that simple empirical models can provide more accurate results than complex empirical models.
Conflict of interest statement
Iftekhar Mahmood has no conflicts of interest that are directly relevant to the content of this article. Current position: Founder and CEO of Mahmood Clinical Pharmacology Consultancy, LLC, Rockville, MD, USA.
Similar articles
-
Age- and Bodyweight-dependent Allometric Exponent Model for Scaling Clearance and Maintenance Dose of Theophylline From Neonates to Adults.Ther Drug Monit. 2018 Oct;40(5):635-641. doi: 10.1097/FTD.0000000000000543. Ther Drug Monit. 2018. PMID: 30086085
-
Multistep Unified Models Using Prior Knowledge for the Prediction of Drug Clearance in Neonates and Infants.J Clin Pharmacol. 2018 Jul;58(7):877-884. doi: 10.1002/jcph.1089. Epub 2018 Feb 28. J Clin Pharmacol. 2018. PMID: 29489016
-
Prediction of propofol clearance in children from an allometric model developed in rats, children and adults versus a 0.75 fixed-exponent allometric model.Clin Pharmacokinet. 2010 Apr;49(4):269-75. doi: 10.2165/11319350-000000000-00000. Clin Pharmacokinet. 2010. PMID: 20214410
-
Pharmacokinetics of Fentanyl and Its Derivatives in Children: A Comprehensive Review.Clin Pharmacokinet. 2018 Feb;57(2):125-149. doi: 10.1007/s40262-017-0569-6. Clin Pharmacokinet. 2018. PMID: 28688027 Free PMC article. Review.
-
All You Need to Know About Allometric Scaling: An Integrative Review on the Theoretical Basis, Empirical Evidence, and Application in Human Pharmacology.Clin Pharmacokinet. 2025 Feb;64(2):173-192. doi: 10.1007/s40262-024-01444-6. Epub 2024 Dec 7. Clin Pharmacokinet. 2025. PMID: 39644458 Free PMC article. Review.
Cited by
-
A Simple Method for the Prediction of Therapeutic Proteins (Monoclonal and Polyclonal Antibodies and Non-Antibody Proteins) for First-in-Pediatric Dose Selection: Application of Salisbury Rule.Antibodies (Basel). 2022 Oct 21;11(4):66. doi: 10.3390/antib11040066. Antibodies (Basel). 2022. PMID: 36278619 Free PMC article.
References
-
- Gibaldi M, Perrier D. Pharmacokinetics. 2. New York: Marcel Dekker; 1982.
-
- Phoenix WinNonlin 8. Certara USA, Inc., Princeton.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources